Display Settings:

Format

Send to:

Choose Destination
    CMAJ. 2006 Feb 28;174(5):649-59.

    Hepatitis C: a review for primary care physicians.

    Source

    Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada and the University of Ottawa, Ottawa, Ont. tom_wong@hc-sc.gc.ca

    Erratum in

    • CMAJ. 2006 May 9;174(10):1450.

    Abstract

    Primary care physicians see many of the estimated 250 000 Canadians chronically infected with the hepatitis C virus (HCV). Of this number, about one-third are unaware they are infected, which constitutes a large hidden epidemic. They continue to spread HCV unknowingly and cannot benefit from advances in antiviral therapy that may clear them of the virus. Many HCV-infected people remain asymptomatic, which means it is important to assess for risk factors and test patients accordingly. The third-generation enzyme immunoassay for HCV antibodies is a sensitive and specific test, although the presence of the virus can be confirmed by polymerase chain reaction testing for HCV RNA in some circumstances. Pegylated interferon-alpha and ribavirin combination therapy clears the virus in about 45%-80% of patients, depending on viral genotype. Preventive strategies and counselling recommendations are also reviewed.

    PMID:
    16505462
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1389829
    Free PMC Article

    Images from this publication.See all images (6) Free text

    Box 2
    Box 3
    Box 1

      Supplemental Content

      Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk